Your browser doesn't support javascript.
loading
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.
Heim, Catrin; Moser, Laura M; Kreyenberg, Herman; Bonig, Halvard B; Tonn, Torsten; Wels, Winfried S; Gradhand, Elise; Ullrich, Evelyn; Meister, Michael T; Koerkamp, Marian Groot; Holstege, Frank C P; Drost, Jarno; Klusmann, Jan-Henning; Bader, Peter; Merker, Michael; Rettinger, Eva.
Afiliación
  • Heim C; Goethe University Frankfurt, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt am Main, Germany.
  • Moser LM; Goethe University Frankfurt, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt am Main, Germany.
  • Kreyenberg H; German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, a Partnership Between DKFZ, University Hospital and Georg-Speyer-Haus, Frankfurt am Main, Germany.
  • Bonig HB; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.
  • Tonn T; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.
  • Wels WS; Goethe University Frankfurt, Department of Pediatrics, Division for Stem Cell Transplantation, Immunology and Intensive Care Medicine, Frankfurt am Main, Germany.
  • Gradhand E; Department of Cellular Therapeutics/Cell Processing, Institute for Transfusion Medicine and Immunotherapy, Goethe University, Frankfurt am Main, Germany.
  • Ullrich E; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, United States.
  • Meister MT; Experimental Transfusion Medicine, Faculty of Medicine Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Koerkamp MG; German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.
  • Holstege FCP; German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, a Partnership Between DKFZ, University Hospital and Georg-Speyer-Haus, Frankfurt am Main, Germany.
  • Drost J; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt am Main, Germany.
  • Klusmann JH; Georg-Speyer-Haus, Institute for Tumor Biology and Experimental Therapy, Frankfurt am Main, Germany.
  • Bader P; Universitäres Centrum für Tumorerkrankungen (UCT), Frankfurt am Main, Germany.
  • Merker M; Dr. Senckenberg Institute of Pathology, University Hospital Frankfurt, Frankfurt, Germany.
  • Rettinger E; German Cancer Consortium (DKTK), Partner Site Frankfurt am Main, a Partnership Between DKFZ, University Hospital and Georg-Speyer-Haus, Frankfurt am Main, Germany.
Front Immunol ; 14: 1228894, 2023.
Article en En | MEDLINE | ID: mdl-37662907
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Neoplasias Primarias Secundarias / Rabdomiosarcoma Alveolar / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Neoplasias Primarias Secundarias / Rabdomiosarcoma Alveolar / Receptores Quiméricos de Antígenos Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Front Immunol Año: 2023 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Suiza